Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Apr 15;12:229–239. doi: 10.2147/CCID.S196110

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 Bianchini et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Treatment with the gel matrix formula significantly improved skin hydration and barrier function. (A) Paired t-test evaluation showed significant (p≤0.05) improvements compared to baseline in corneometer measurements at week 1 and week 12. (B) 78.8% of subjects showed improvements in surface skin hydration as soon as week 1 and 89.3% of subjects showed improvements by week 12. (C, D) Paired t-test evaluation showed significant (p≤0.05) improvements compared to baseline in tewameter measurements at week 12, which corresponded to a 64.3% of subjects showing improvements in barrier function.